Related Experiment Video
Updated: Aug 11, 2026
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Locoregional therapies for glioma
1Department of General and Oncological Surgery, City of Hope Cancer Center Duarte, California, USA.
Abstract:
Glioma is the most common form of primary brain tumor, as well as the most lethal. Primary treatment strategies for glioma, including cytoreductive surgery, external-beam irradiation, and systemic chemotherapy have had generally disappointing results for these tumors. Limitations of these approaches include tumor invasion into functional brain tissue, lack of chemosensitivity, and shortcomings of systemic delivery. Recent attention has focused on locoregional strategies for treatment, as well as new methods for delivering therapy. Identification of tumor-specific surface targets, biologic agents, and more sophisticated means to deliver macromolecules to the brain is offering new promise in the treatment of these tumors. This paper will review the current state of the art of available locoregional therapies for glioma, with a particular focus on convection-enhanced delivery, targeted toxin, and other biologic strategies.
Insights
Locoregional therapies offer new promise for treating lethal brain tumors like glioma. Advanced methods like convection-enhanced delivery and targeted toxins improve treatment efficacy by overcoming limitations of traditional approaches.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pharmacology
Background:
- Glioma is the most common and lethal primary brain tumor.
- Current treatments (surgery, radiation, chemotherapy) show limited success due to tumor invasion and delivery challenges.
- New therapeutic strategies are needed for improved glioma treatment.
Purpose of the Study:
- To review current locoregional therapies for glioma.
- To highlight promising biologic and delivery strategies for brain tumors.
- To focus on convection-enhanced delivery and targeted toxins.
Main Methods:
- Review of existing literature on glioma locoregional therapies.
- Analysis of novel drug delivery systems for brain tumors.
- Evaluation of biologic agents and targeted toxins for glioma treatment.
Main Results:
- Locoregional strategies show potential to overcome limitations of systemic therapy.
- Convection-enhanced delivery allows for direct, targeted drug administration.
- Targeted toxins and biologic agents offer specific anti-glioma activity.
Conclusions:
- Locoregional therapies, particularly convection-enhanced delivery and targeted toxins, represent a promising advancement in glioma treatment.
- Sophisticated delivery methods and identification of tumor-specific targets are crucial for future therapeutic success.
- Further research into these novel strategies is warranted for improved patient outcomes in glioma care.
